NCT03382002

Brief Summary

Medium of cumulus-oocyte complex will be assessed for oxidative status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
322

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 29, 2017

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 22, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2020

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

2 years

First QC Date

November 29, 2017

Last Update Submit

January 31, 2019

Conditions

Oxidative Stress

Outcome Measures

Primary Outcomes (1)

  • Association of parameters of oxidative state with cycle outcome (pregnancy: yes/no)

    The oxidative status in the incubation medium of the cumulus-oocyte complex will be assessed looking for an association between oxidative parameters and cycle outcome (pregnancy: yes/no))

    two years

Interventions

TCLDIAGNOSTIC_TEST

evaluation of oxidative status

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale only
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing in vitro fertilization

You may qualify if:

  • Patients undergoing in vitro fertilization treatment

You may not qualify if:

  • Patients undergoing intracytoplasmic sperm injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel medical Center

Haifa, Israel

RECRUITING

Central Study Contacts

Zofnat Wiener, MD

CONTACT

97248250335wiener_zofnat@clalit.org.il

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 29, 2017

First Posted

December 22, 2017

Study Start

November 28, 2017

Primary Completion

November 28, 2019

Study Completion

April 28, 2020

Last Updated

February 1, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations

IL(1)